EFFECT OF TRANSCRANIAL MAGNETIC STIMULATION IN INDIVIDUAL WITH NEUROPATHIC OROFACIAL PAIN

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400092014

Enrollment

Unknown

Registered

2024-11-07

Start date

2024-04-08

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NEUROPATHIC OROFACIAL PAIN(NOP)

Interventions

peripheral stimultion group:Using transcranial magnetic stimulation to stimulate the peripheral points in patients

central stimulation group:Using transcranial magnetic stimulation to stimulate the motor cortex in patients

Combined stimulation group:Using transcranial magnetic stimulation the motor cortex and peripheral points

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Diagnosed as, (2) medically stable, (3) syndrome in duration at least 6 moths, and there is a history of medication treatment, (4) the absence of severe organic brain damage or other serious diseases, which could interfere with rTMS (epilepsy) and the absence of any metallic implants in the body, (5) 18-75 years of age.

Exclusion criteria

Exclusion criteria: (1) neurological disorders in addition to NOP, (2) major mental illness, (3) epilepsy, (4) cardiac pace-maker, (5) patients with medication changes within 4 weeks of the start of the trial or during the trial, (6) vestibular disorders, and other serious illnesses

Design outcomes

Primary

Measure	Time frame
Visual analogue scale (VAS);	—

Secondary

Measure	Time frame
The Beck Depression Inventory (BDI);Patients' Global Impression of Change (PGIC) Scale;	—

Countries

CHINA

Contacts

Public ContactLiao Manxia

Yixing JORU Rahibilitation Hospital

liaomanxia@126.com+86 137 1125 5054

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026